1 active not recruiting, 1 completed, 1 not yet recruiting, 1 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Not yet recruiting 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Aston Sci. Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer AST-201, Paclitaxel, Carboplatin - Advanced Ovarian Cancer | Phase 2 | Not yet recruiting | Aston Sci. Inc. | 98 | 2027-06-01 | 2026-10-27 |
| Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric Cancer AST-301, rhuGM-CSF - Gastric Cancer | Phase 2 | Active not recruiting | Aston Sci. Inc. | 24 | 2023-07-04 | 2026-07-22 |
| Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer AST-301(pNGVL3-hICD), rhuGM-CSF, Placebo - Breast Cancer | Phase 2 | Terminated | Aston Sci. Inc. | 10 | 2022-02-28 | 2024-06-17 |
| AST-021p Study in Advanced Solid Tumors AST-021p - Advanced Cancer | Phase 1 | Completed | Aston Sci. Inc. | 22 | 2021-06-09 | 2026-07-22 |
Breast Neoplasms (1) · Stomach Neoplasms (1)
sargramostim (3) · Saline Solution (2) · Capecitabine (1) · Carboplatin (1) · Paclitaxel (1) · pembrolizumab (1)
Taiwan (2) · United States (2) · South Korea (1)
Hun Jung, MD (1) · Hun Jung, MD, PhD (1) · Kyong Hwa Park, MD. PhD (1)